# Trade Mark Journal No.2026/012 20 March 2026

## WO0000001892553 (5,35,36,42,44)

Office of origin: United States of America

Date of International Registration:18 August 2025
Date of designation in the UK: 18 August 2025

International priority date claimed: 21 February 2025 (United States of America) (99051997)

Class 5
  Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; enzymes for medical purposes, namely, for facilitating delivery of fluids or pharmaceuticals; drug delivery agents consisting of pharmaceuticals containing enzymes that facilitate delivery of fluids and a wide range of pharmaceuticals; pharmaceutical preparations for use in the treatment and prevention of metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, dermatological conditions and disorders, and for the treatment of cancer and in hydration; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in aesthetic skin treatments; hyaluronic acid for pharmaceutical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures; enzymes for medical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures.
Class 35
  Administration of a discount program enabling patients to obtain discounts on prescription drugs through use of a discount card provided by a copay discount program; business administration of a program enabling patients to obtain discounts on prescription drugs through a cash-pay program for uninsured and underinsured patients.
Class 36
  Insurance benefits verification and prior authorization assistance in the health industry; copay assistance programs, namely, providing financial assistance to uninsured and underinsured patients for prescription medications.
Class 42
  Scientific research and development services for the integration of technologies, therapies, and other systems for pharmaceuticals and drug delivery systems.
Class 44
  Providing medical information in the field of subcutaneous fluid administration; providing medical information in the field of subcutaneous delivery of a wide range of pharmaceuticals.

Halozyme, Inc.

Representative: Gene K. Park Morgan, Lewis & Bockius LLP, One Market, Spear Street Tower, San Francisco CA 94105, UNITED STATES OF AMERICA